T1-mapping by Cardiovascular Magnetic Resonance Imaging to Assess Non-Alcoholic Fatty Liver Disease

N/AUnknownNCT04220450

Dr. Andreas Kammerlander800 enrolled

Overview

On clinically indicated Cardiovascular Magnetic Resonance studies, native T1-times and extracellular volume of the liver will be assessed and findings correlated with established risk calculators for non-alcoholic fatty liver disease.

Study Type

OBSERVATIONAL

Enrollment

800

Conditions

NAFLD Heart Failure Valvular Disease Coronary Disease

Interventions

T1 mapping on Cardiovascular Magnetic Resonance StudiesDIAGNOSTIC_TEST

On clinically indicated Cardiovascular Magnetic Resonance Imaging Studies, native T1-times and extracellular volume will be determined

Eligibility

Sex: ALLMin age: 18 Months

Medical Language ↔ Plain English

Inclusion Criteria: * Referred for Cardiovascular Magnetic Resonance Imaging Exclusion Criteria: * Non-compatible Devices

Locations (1)

Medical University of Vienna

Vienna, Austria

Outcomes

Primary Outcomes

Correlation NAFLD and liver T1mapping

Correlation NAFLD risk score and liver T1-mapping (native and ECV9

Time frame: cross-sectional within one year

Central Contacts

Andreas Kammerlander, MD PhD

CONTACT

0043 1 40400 46140 andreas.kammerlander@meduniwien.ac.at

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.